[
  {
    "ts": "2026-02-05T03:08:35+00:00",
    "headline": "AbbVie Q4 Earnings Call Highlights",
    "summary": "AbbVie (NYSE:ABBV) executives said the company closed 2025 with record revenue and earnings above initial expectations, citing strong performance from its “ex-Humira growth platform,” continued momentum for Skyrizi and Rinvoq, and expanding contributions from neuroscience and other franchises. On t",
    "url": "https://www.marketbeat.com/instant-alerts/abbvie-q4-earnings-call-highlights-2026-02-04/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "2f02ce2f-6118-371f-8c71-c28922ffed8f",
      "content": {
        "id": "2f02ce2f-6118-371f-8c71-c28922ffed8f",
        "contentType": "STORY",
        "title": "AbbVie Q4 Earnings Call Highlights",
        "description": "",
        "summary": "AbbVie (NYSE:ABBV) executives said the company closed 2025 with record revenue and earnings above initial expectations, citing strong performance from its “ex-Humira growth platform,” continued momentum for Skyrizi and Rinvoq, and expanding contributions from neuroscience and other franchises. On t",
        "pubDate": "2026-02-05T03:08:35Z",
        "displayTime": "2026-02-05T03:08:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/d14f178b61e5d1b3f07aed92c6bf5868",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "AbbVie logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lCHq.E1saNbd6P5A_hygCw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/d14f178b61e5d1b3f07aed92c6bf5868.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jidNKNPfHTagH3j2JawAnw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/d14f178b61e5d1b3f07aed92c6bf5868.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/abbvie-q4-earnings-call-highlights-2026-02-04/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-q4-earnings-call-highlights-030835847.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T05:32:45+00:00",
    "headline": "ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds",
    "summary": "Pharmaceutical company AbbVie (NYSE:ABBV) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 6% year on year to $16 billion. Its non-GAAP profit of $2.71 per share was 2.2% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/abbv-q4-deep-dive-immunology-053245917.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "3ee31399-0ea8-36bb-8038-0ed4778b7d33",
      "content": {
        "id": "3ee31399-0ea8-36bb-8038-0ed4778b7d33",
        "contentType": "STORY",
        "title": "ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds",
        "description": "",
        "summary": "Pharmaceutical company AbbVie (NYSE:ABBV) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 6% year on year to $16 billion. Its non-GAAP profit of $2.71 per share was 2.2% above analysts’ consensus estimates.",
        "pubDate": "2026-02-05T05:32:45Z",
        "displayTime": "2026-02-05T05:32:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ABBV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K222hrzb0FJJlqrDZzsz7w--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cD3IChyAhZhexmnMXW7jMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/621a415265c388bc8e9eb8ecaf0fb0a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbv-q4-deep-dive-immunology-053245917.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbv-q4-deep-dive-immunology-053245917.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]